Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Kumamoto, 860-8556, Japan,
Clin Exp Nephrol. 2010 Oct;14(5):405-10. doi: 10.1007/s10157-010-0299-7. Epub 2010 Jun 11.
Sodium balance, extracellular fluid volume, and ultimately blood pressure are maintained by precise regulation of the activity of epithelial sodium channels (ENaC). Multiple mechanisms such as hormones, intracellular factors, and other regulatory factors contribute to regulation of ENaC activity. Prostasin, a glycosylphosphatidylinositol-anchored serine protease, has been identified as an activator of ENaC that increases its open probability. Furin cleaves αENaC at two sites and γENaC at one site at the Golgi. Prostasin cleaves γENaC at one site that is distinct from the furin site at the plasma membrane. Dual cleavage of α- and γ-subunit releases inhibitory segments from ENaC, leading to channel activation. Protease nexin-1 (PN-1), an endogenous prostasin inhibitor, inhibits ENaC activity through suppression of prostasin activity. Aldosterone and transforming growth factor-β1 reciprocally regulate expression of prostasin, PN-1, and ENaC in renal epithelial cell, resulting in sodium retention or natriuresis, respectively. These findings strongly suggest the possibility that coordinated regulation of serine protease, serpin, and ENaC expression plays a key role in sodium handling in the kidney.
钠平衡、细胞外液量,最终是血压,都是通过对上皮钠通道 (ENaC) 活性的精确调节来维持的。多种机制,如激素、细胞内因子和其他调节因子,有助于 ENaC 活性的调节。原蛋白酶是一种糖基磷脂酰肌醇锚定的丝氨酸蛋白酶,已被确定为 ENaC 的激活剂,可增加其开放概率。弗林在高尔基体内切割 αENaC 两个位点和 γENaC 一个位点。原蛋白酶在质膜上不同于弗林位点的一个位点切割 γENaC。α-和 γ-亚基的双重切割从 ENaC 释放抑制片段,导致通道激活。蛋白酶抑制剂-1(PN-1),一种内源性原蛋白酶抑制剂,通过抑制原蛋白酶的活性来抑制 ENaC 活性。醛固酮和转化生长因子-β1 相互调节肾上皮细胞中原蛋白酶、PN-1 和 ENaC 的表达,分别导致钠潴留或排钠。这些发现强烈表明,丝氨酸蛋白酶、丝氨酸蛋白酶抑制剂和 ENaC 表达的协调调节可能在肾脏的钠处理中起关键作用。